Index-Nr.
|
Chemische Bezeichnung
|
EG-Nr.
|
CAS-Nr.
|
Einstufung
|
Kennzeichnung
|
Spezifische Konzentrationsgrenzen, M-Faktoren und ATE
|
Anmerkungen
|
Kodierung der Gefahrenklassen und -kategorien
|
Kodierung der Gefahrenhinweise
|
Piktogramm, Kodierung der Signalworte
|
Kodierung der Gefahrenhinweise
|
Kodierung der ergänzenden Gefahrenmerkmale
|
„006-015-00-9
|
Diuron (ISO); 3-(3,4-Dichlorphenyl)-1,1-dimethylharnstoff
|
206-354-4
|
330-54-1
|
Carc. 1B
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H350
H373 (Blutkreislauf)
H400
H410
|
GHS08
GHS09
Dgr
|
H350
H373 (Blutkreislauf)
H410
|
|
M = 100
M = 100“
|
|
„015-203-00-X
|
Diphenyl(2,4,6-trimethylbenzoyl)phosphinoxid
|
278-355-8
|
75980-60-8
|
Repr. 1B
Skin Sens. 1B
|
H360Fd
H317
|
GHS08
GHS07
Dgr
|
H360Fd
H317“
|
|
|
|
„016-001-00-4
|
Schwefelwasserstoff
|
231-977-3
|
7783-06-4
|
Flam. Gas 1A
Press. Gas
Acute Tox. 2
Aquatic Acute 1
|
H220
H330
H400
|
GHS02
GHS06
GHS09
Dgr
|
H220
H330
H400
|
|
Inhalation: ATE = 440 ppmV (Gase)
|
U“
|
„016-011-00-9
|
Schwefeldioxid
|
231-195-2
|
7446-09-5
|
Press. Gas
Acute Tox. 3
STOT SE 1
Skin. Corr. 1B
|
H331
H370 (Atmungsorgane) (Inhalation)
H314
|
GHS04
GHS06
GHS08
GHS05
Dgr
|
H331
H370 (Atmungsorgane) (Inhalation)
H314
|
|
Inhalation: ATE = 1 000 ppmV (Gase)
|
U, 5“
|
„017-004-00-3
|
Kaliumchlorat
|
223-289-7
|
3811-04-9
|
Ox. Sol. 1
Acute Tox. 3
|
H271
H301
|
GHS03
GHS06
Dgr
|
H271
H301
|
|
Oral: ATE = 100 mg/kg KG“
|
|
„017-005-00-9
|
Natriumchlorat
|
231-887-4
|
7775-09-9
|
Ox. Sol. 1
Acute Tox. 3
|
H271
H301
|
GHS03
GHS06
Dgr
|
H271
H301
|
|
Oral: ATE = 100 mg/kg KG“
|
|
„082-013-00-1
|
Bleipulver;
[Partikeldurchmesser < 1 mm]
|
231-100-4
|
7439-92-1
|
Repr. 1A
Lact.
Aquatic Acute 1
Aquatic Chronic 1
|
H360FD
H362
H400
H410
|
GHS08
GHS09
Dgr
|
H360FD
H362
H410
|
|
Repr. 1A;
H360D: C ≥ 0,03 %
M = 10
M = 100“
|
|
„082-014-00-7
|
Blei, massiv:
[Partikeldurchmesser ≥ 1 mm]
|
231-100-4
|
7439-92-1
|
Repr. 1A
Lact.
Aquatic Chronic 1
|
H360FD
H362
H410
|
GHS08
GHS09
Dgr
|
H360FD
H362
H410
|
|
M = 10“
|
|
„603-057-00-5
|
Benzylalkohol
|
202-859-9
|
100-51-6
|
Acute Tox. 4
Eye Irrit. 2
Skin Sens. 1B
|
H302
H319
H317
|
GHS07
Wng
|
H302
H319
H317
|
|
Oral: ATE = 1 200 mg/kg KG“
|
|
„604-010-00-1
|
Resorcin; 1,3-Dihydroxybenzol
|
203-585-2
|
108-46-3
|
Acute Tox. 4
STOT SE 1
Skin Irrit. 2
Eye Irrit. 2
Skin Sens. 1B
Aquatic Acute 1
|
H302
H370 (Nervensystem)
H315
H319
H317
H400
|
GHS07
GHS08
GHS09
Dgr
|
H302
H370 (Nervensystem)
H315
H319
H317
H400
|
|
Oral: ATE = 500 mg/kg KG
M = 1“
|
|
„604-074-00-0
|
2,2‘,6,6’-Tetrabrom-4,4’-isopropylidenediphenol; Tetrabrombisphenol-A
|
201-236-9
|
79-94-7
|
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
H350
H400
H410
|
GHS08
GHS09
Dgr
|
H350
H410“
|
|
|
|
„606-034-00-8
|
Metribuzin (ISO); 4-Amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-on; 4-Amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-on
|
244-209-7
|
21087-64-9
|
Acute Tox. 4
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H373 (Blutkreislauf)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H302
H373 (Blutkreislauf)
H410
|
|
Oral: ATE = 320 mg/kg KG
M = 10
M = 10“
|
|
„607-032-00-X
|
Ethylacrylat
|
205-438-8
|
140-88-5
|
Flam. Liq. 2
Acute Tox. 3
Acute Tox. 4
Acute Tox. 4
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2
Skin Sens. 1
|
H225
H331
H312
H302
H335
H315
H319
H317
|
GHS02
GHS06
Dgr
|
H225
H331
H312
H302
H335
H315
H319
H317
|
|
Inhalation: ATE = 9 mg/L (Dämpfe)
dermal: ATE = 1 800 mg/kg KG
Oral: ATE = 1 120 mg/kg KG
STOT SE 3; H335: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %
Eye Irrit. 2; H319: C ≥ 5 %
|
D“
|
„607-034-00-0
|
Methylacrylat;
Methlproenoat
|
202-500-6
|
96-33-3
|
Flam. Liq. 2
Acute Tox. 3
Acute Tox. 4
Acute Tox. 4
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2
Skin Sens. 1
|
H225
H331
H312
H302
H335
H315
H319
H317
|
GHS02
GHS06
Dgr
|
H225
H331
H312
H302
H335
H315
H319
H317
|
|
Inhalation: ATE = 3 mg/L (Dämpfe)
dermal: ATE = 1 100 mg/kg KG
Oral: ATE = 500 mg/kg KG
|
D“
|
„607-223-00-8
|
Transfluthrin (ISO); 2,3,5,6-Tetrafluorbenzyl (1R,3S)-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat
|
405-060-5
|
118712-89-3
|
Carc. 2
Acute Tox. 4
STOT SE 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H302
H370 (Nervensystem)
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H351
H302
H370 (Nervensystem)
H410
|
EUH066
|
Oral: ATE = 580 mg/kg KG
M = 1 000
M = 1 000 “
|
|
„607-246-00-3
|
Allylmethacrylat;
2-Methyl-2-propensäure 2-propenylester
|
202-473-0
|
96-05-9
|
Flam. Liq. 3
Acute Tox. 2
Acute Tox. 3
Acute Tox. 4
Aquatic Acute 1
|
H226
H330
H311
H302
H400
|
GHS02
GHS06
GHS09
Dgr
|
H226
H330
H311
H302
H400
|
|
Inhalation: ATE = 1,5 mg/L (Dämpfe)
dermal: ATE = 300 mg/kg KG
Oral: ATE = 400 mg/kg KG“
|
|
„612-004-00-5
|
Triethylamin
|
204-469-4
|
121-44-8
|
Flam. Liq. 2
Acute Tox. 3
Acute Tox. 3
Acute Tox. 3
Skin Corr. 1A
Eye Dam. 1
|
H225
H331
H311
H301
H314
H318
|
GHS02
GHS06
GHS05
Dgr
|
H225
H331
H311
H301
H314
|
|
Inhalation: ATE = 7,2 mg/L (Dämpfe)
dermal: ATE = 300 mg/kg KG
oral: ATE = 100 mg/kg KG STOT SE 3; H335: C ≥ 1 %“
|
|
„612-049-00-0
|
Di-n-Butylamin
|
203-921-8
|
111-92-2
|
Flam. Liq. 3
Acute Tox. 2
Acute Tox. 3
Acute Tox. 3
Skin Corr. 1B
Eye Dam. 1
|
H226
H330
H311
H301
H314
H318
|
GHS02
GHS06
GHS05
Dgr
|
H226
H330
H311
H301
H314
|
EUH 071
|
Inhalation: ATE = 1,2 mg/L (Dämpfe) dermal: ATE = 300 mg/kg KG
Oral: ATE = 220 mg/kg KG“
|
|
„612-056-00-9
|
N,N-Dimethyl-m-toluidin; [1]
N,N-Dimethyl-o-toluidin [2]
|
204-495-6 [1] 210-199-8 [2]
|
121-72-2 [1] 609-72-3 [2]
|
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3
|
H331
H311
H301
H373 **
H412
|
GHS06 GHS08
Dgr
|
H331
H311
H301
H373 **
H412
|
|
*
|
C“
|
„613-088-00-6
|
1,2-Benzisothiazol-3(2H)-on; 1,2-Benzisothiazolin-3-on
|
220-120-9
|
2634-33-5
|
Acute Tox. 2
Acute Tox. 4
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H315
H318
H317
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H315
H318
H317
H410
|
|
Inhalation:
ATE = 0,21 mg/L (Stäube oder Nebel)
Oral: ATE = 450 mg/kg KG
Skin Sens. 1A; H317: C ≥ 0,036 %
M = 1
M = 1“
|
|
„613-127-00-7
|
Mepiquatchlorid (ISO); 1,1-Dimethylpiperidiniumchlorid
|
246-147-6
|
24307-26-4
|
Acute Tox. 4
Acute Tox. 3
Aquatic Chronic 3
|
H332
H301
H412
|
GHS06
Dgr
|
H332
H301
H412
|
|
Inhalation: ATE = 2,8 mg/L (Stäube oder Nebel)
Oral:
ATE = 270 mg/kg KG“
|
|
„613-307-00-5
|
Clothianidin (ISO); (E)-1-(2-Chlor-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidin
|
433-460-1
|
210880-92-5
|
Repr. 2
Acute Tox. 4
STOT SE 1
Aquatic Acute 1
Aquatic Chronic 1
|
H361f
H302
H370 (Nervensystem)
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H361f
H302
H370 (Nervensystem)
H410
|
|
Oral: ATE = 390 mg/kg KG
M = 10
M = 100“
|
|
„616-035-00-5
|
Cymoxanil (ISO); 2-Cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamid; [1]
(2E)-2-Cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamid; [2]
|
261-043-0 [1]
- [2]
|
57966-95-7 [1]
166900-80-7 [2]
|
Repr. 2
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H361fd
H302
H373 (Blutkreislauf, Thymusdrüse, Augen)
H317
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H361fd
H302
H373 (Blutkreislauf, Thymusdrüse, Augen)
H317
H410
|
|
Oral: ATE = 360 mg/kg KG
M = 1
M = 1“
|
|
„616-104-00-X
|
Benalaxyl (ISO); Methyl-N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninat.
|
275-728-7
|
71626-11-4
|
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H400
H410
|
GHS07
GHS09
Wng
|
H302
H410
|
|
Oral: ATE = 1 000 mg/kg KG
M = 1
M = 1“
|
|